Skip to main content
Chatchada Karanes, MD, Hematology, Duarte, CA, City of Hope Comprehensive Cancer Center

ChatchadaKaranesMD

Hematology Duarte, CA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Director, Cord blood transplant program

Dr. Karanes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Karanes' full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1976 - 1977
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1975 - 1976
  • Ascension Illinois/Saint Francis
    Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1973 - 1975
  • Ascension Illinois/Saint Francis
    Ascension Illinois/Saint FrancisInternship, Transitional Year, 1972 - 1973
  • Mahidol University Faculty of Medicine
    Mahidol University Faculty of MedicineClass of 1971

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1975 - Present
  • CA State Medical License
    CA State Medical License 2004 - 2024
  • MN State Medical License
    MN State Medical License 2001 - 2005
  • MI State Medical License
    MI State Medical License 1979 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • First-in-Human Imaging of Multiple Myeloma Using Copper-64-Labeled Daratumumab: Preliminary Results
    Chatchada Karanes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...
    Chatchada Karanes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable Remissions
    Chatchada Karanes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Professional Memberships

Hospital Affiliations